SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2170418

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2170418

Irradiation Apparatus Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Irradiation Apparatus Market exceeded USD 7.43 billion in 2025 and is projected to grow at 5.25% CAGR to reach USD 12.41 billion by 2035. Equipment purchasing reflects replacement within established oncology and imaging networks as well as the creation of treatment capacity in underserved health systems. Providers increasingly evaluate apparatus alongside planning software, imaging integration, and clinical workflow requirements.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$7.43 Billion
Forecast Value$12.41 Billion
CAGR5.25%

Higher cancer incidence increases the need for treatment and diagnostic capacity, encouraging hospitals to address aging equipment and operating constraints. Procurement can support improved planning, treatment throughput, and service availability even where providers are not building entirely new centers. In markets with inadequate radiotherapy infrastructure, national cancer programs and multilateral initiatives create demand for treatment delivery, simulation, dosimetry, and related equipment. These projects require site preparation, training, approvals, and commissioning before routine operation. Suppliers able to provide financing, local service, and training can better address that development sequence. Advanced imaging and AI-enabled adaptive radiotherapy also encourage replacement in mature health systems. Buyers increasingly consider how apparatus supports coordinated planning and repeatable clinical workflows in addition to treatment delivery. This shifts purchasing toward software-integrated platforms and upgrade pathways that allow institutions to modernize established equipment environments while maintaining dependable oncology services.

Based on type, X-ray irradiators contributed revenue of USD 2.08 billion in 2025. X-ray alternatives participate in the gradual replacement of established source-based systems where customers seek more operating flexibility and simpler source handling. Their role sits within a broader apparatus category in which image guidance, adaptive planning, and digital connectivity increasingly influence procurement. Equipment selection varies with the intended application and facility requirements, while practical installation and integrated capabilities shape the proposition offered by suppliers serving clinical and industrial purchasing environments.

By application, therapy/radiotherapy is forecast to generate USD 6.30 billion by 2035. Radiation treatment's role within cancer care creates a continuing need for reliable therapeutic capability. Accredited cancer centers and oncology networks must consider replacement, modernization, and capacity expansion when maintaining services. These requirements provide a more persistent procurement basis than discretionary capital purchasing alone. The commercial opportunity depends on meeting providers' clinical and operating needs as treatment pathways become more integrated. Apparatus suppliers can compete through dependable equipment, relevant planning functionality, and support that helps institutions sustain treatment availability within high-volume oncology environments and established care programs.

The North America irradiation apparatus market is forecast to reach USD 4.59 billion by 2035. An extensive installed base, mature reimbursement arrangements, and academic cancer centers support demand for high-value replacement equipment. Providers increasingly prioritize guided imaging, adaptive workflows, and integrated software when assessing modernization. Service networks and a credible clinical installation history consequently influence supplier selection. The purchasing opportunity extends beyond replacing equipment with similar hardware: institutions also evaluate how a new platform fits planning and treatment operations. Suppliers with established support capabilities can address those requirements where long-term reliability and workflow compatibility are important to capital-equipment decisions.

Siemens Healthineers represented 33.2% of global market revenue during 2025. Its Varian business gives it capabilities across treatment apparatus, planning software, oncology information systems, and proton therapy. The connection between these functions supports competition on workflow continuity as well as equipment performance. Providers with integrated installations face switching considerations because replacing a platform can affect several linked clinical systems. This breadth strengthens the company's relevance in procurement where customers evaluate the wider operating environment around treatment delivery. Its market position reflects the importance of combining apparatus with software and established clinical relationships in a sector shaped by regulatory qualification and ongoing support requirements.

Some of the major players in this market are GE HealthCare, Elekta, Koninklijke Philips, Canon Medical Systems, Accuray, Hitachi, Mevion Medical Systems, Mindray, Neusoft Medical Systems, Panacea Medical Technologies, Shinva Medical, Sumitomo Heavy Industries, and ViewRay. GE HealthCare and imaging specialists participate through diagnostic and planning capabilities, while Elekta emphasizes radiotherapy and adaptive treatment. Accuray addresses focused precision applications, and proton therapy suppliers compete through accelerator engineering and project execution. Compact configurations can reduce facility demands, while regional manufacturers serve cost-sensitive procurement. Installed experience, qualification resources, service reach, and the ability to integrate apparatus within clinical workflows remain significant competitive considerations across these different equipment positions.

Product Code: 14256

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Scope and Definitions
  • 1.2 Research Design
    • 1.2.1 Research Approach
    • 1.2.2 Data Collection Methods
  • 1.3 Data Mining Sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base Estimates and Calculations
    • 1.4.1 Base Year Calculation
    • 1.4.2 Key Trends for Market Estimation
  • 1.5 Primary Research and Validation
    • 1.5.1 Primary Sources
  • 1.6 Forecast Model
  • 1.7 Research Assumptions and Limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° Synopsis
  • 2.2 Key Market Trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Application
    • 2.2.4 End Use
  • 2.3 CXO Perspectives: Strategic Imperatives
    • 2.3.1 Key Decision Points for Industry Executives
    • 2.3.2 Critical Success Factors for Market Players
  • 2.4 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry Ecosystem Analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Factors Affecting the Value Chain
  • 3.2 Industry Impact Forces
    • 3.2.1 Growth Drivers
      • 3.2.1.1 Rising Incidence of Cancer and Chronic Diseases
      • 3.2.1.2 Technological Advancements in Imaging and Radiotherapy Equipment
      • 3.2.1.3 Growing Investments in Healthcare Infrastructure
      • 3.2.1.4 Increased Awareness of Blood Safety
    • 3.2.2 Industry Pitfalls and Challenges
      • 3.2.2.1 High Capital Investment and Maintenance Costs
      • 3.2.2.2 Strict Regulatory Approvals and Compliance Requirements
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Adoption of AI and Automation in Imaging Systems
      • 3.2.3.2 Accelerated Demand for Non-Chemical Sterilization
  • 3.3 Growth Potential Analysis
  • 3.4 Regulatory Landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Technology and Innovation Landscape
    • 3.5.1 Current Technological Trends
    • 3.5.2 Emerging Technologies
  • 3.6 Pricing Analysis
  • 3.7 Future Market Trends
  • 3.8 Patent Analysis
  • 3.9 Porter’s Analysis
  • 3.10 PESTEL Analysis
  • 3.11 Consumer Behaviour Analysis

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Competitive Market Share Analysis
  • 4.3 Company Matrix Analysis
  • 4.4 Competitive Analysis of Major Market Players
  • 4.5 Competitive Positioning Matrix
  • 4.6 Key Developments
    • 4.6.1 Mergers & Acquisitions
    • 4.6.2 Partnerships & Collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Type, 2022–2035 ($ Mn)

  • 5.1 Key Trends
  • 5.2 Gamma Irradiators
  • 5.3 X-Ray Irradiators
  • 5.4 Ultraviolet (UV) and Neutron Irradiators
  • 5.5 Electron-Beam Irradiators
  • 5.6 Other Types

Chapter 6. Market Estimates and Forecast, By Application, 2022–2035 ($ Mn)

  • 6.1 Key Trends
  • 6.2 Diagnostic Imaging
  • 6.3 Therapy/Radiotherapy
  • 6.4 Sterilization and Disinfection
  • 6.5 Other Applications

Chapter 7. Market Estimates and Forecast, By End Use, 2022–2035 ($ Mn)

  • 7.1 Key Trends
  • 7.2 Hospitals and Clinics
  • 7.3 Research Laboratories and Institutes
  • 7.4 Other End Use

Chapter 8. Market Estimates and Forecast, By Region, 2022–2035 ($ Mn)

  • 8.1 Key Trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9. Company Profiles

  • 9.1 Accuray
  • 9.2 Canon Medical Systems
  • 9.3 Elekta
  • 9.4 GE HealthCare
  • 9.5 Hitachi
  • 9.6 Koninklijke Philips
  • 9.7 Mevion Medical Systems
  • 9.8 Mindray
  • 9.9 Neusoft Medical Systems
  • 9.10 Panacea Medical Technologies
  • 9.11 Shinva Medical
  • 9.12 Siemens Healthineers
  • 9.13 Sumitomo Heavy Industries
  • 9.14 ViewRay
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!